Xerox Q2: Headline Growth Masks Core Decline; Margin Boost Proves Fleeting

What happened

Xerox's Q2 FY26 results show that reported revenue growth remains acquisition-driven, with pro forma revenue declining 6.5% as core print demand continues to erode. Headline margin expansion was artificially boosted by a one-time tariff benefit, while underlying pro forma operating margin improvement was minimal, confirming that Lexmark synergies are yet to materialize. The 9-Series product launch and ongoing Lexmark integration offer a path to future margin and cost savings, but management has provided limited evidence of sustainable improvement. The balance sheet remains highly leveraged with negative free cash flow, and the near-term focus is on whether warrant-driven deleveraging and synergy capture can inflect before refinancing needs intensify. Until pro forma revenue stabilizes and margins show clear synergy-driven progress, the stock remains a high-risk, option-like bet on integration execution.

Implication

The market is pricing in a deeply distressed scenario; any upgrade requires two to three quarters of consistent pro forma stabilization and synergy-driven margin expansion. Without these, the high leverage and negative free cash flow will continue to weigh on equity, and the risk of capital impairment remains elevated. Activist interest and the warrant deleveraging path could provide upside if debt retirement accelerates, but timing is uncertain. Investors should monitor next quarterly filings for signs that the 9-Series launch and toner transition are arresting the decline, as the current wait-and-see posture remains appropriate.

Thesis delta

The Q2 results further validate our WAIT rating, revealing that the reported growth is cosmetic and that margin gains were partly a tariff windfall. The core thesis—that Lexmark synergies must drive pro forma improvement to offset structural print decline—remains intact, but the evidence of progress has not yet materialized. Consequently, we see no reason to alter our base-case probability; the burden of proof remains on management to deliver in the coming quarters.